1. Home
  2. NSPR vs MOBX Comparison

NSPR vs MOBX Comparison

Compare NSPR & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.85

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

Logo Mobix Labs Inc.

MOBX

Mobix Labs Inc.

HOLD

Current Price

$1.11

Market Cap

33.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
MOBX
Founded
2005
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.7M
33.5M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
NSPR
MOBX
Price
$0.85
$1.11
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
75.5K
901.5K
Earning Date
05-04-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
$6,442,000.00
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
426.31
52 Week Low
$0.63
$0.13
52 Week High
$2.57
$4.25

Technical Indicators

Market Signals
Indicator
NSPR
MOBX
Relative Strength Index (RSI) 58.52 25.19
Support Level $0.66 $0.19
Resistance Level $1.04 $1.33
Average True Range (ATR) 0.07 0.15
MACD 0.02 -0.05
Stochastic Oscillator 54.65 5.35

Price Performance

Historical Comparison
NSPR
MOBX

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About MOBX Mobix Labs Inc.

Mobix Labs Inc designs, develops and sells components and systems for wireless and wired connectivity, radio frequency (RF), switching and electromagnetic interference (EMI) filtering technologies. Its wireless systems solutions include products for RF and millimeter wave (mmWave) communications, mmWave imaging, software defined radio and custom RF integrated circuits (ICs) targeting the defense, aerospace, commercial and industrial sectors. The majority of the company's revenue is derived from product sales to equipment manufacturers. Geographically, it generates the maximum revenue from the United States.

Share on Social Networks: